We are improving our search experience. To check which content you have full access to, or for advanced search, go back to the old search.

Search

Please fill in this field.

Search Results

Showing 101-120 of 8,956 results
  1. Green synthesis of nanohydroxyapatite trough Elaeagnus angustifolia L. extract and evaluating its anti-tumor properties in MCF7 breast cancer cell line

    Background

    One of the most common types of cancer in women is breast cancer. There are numerous natural plant-based products, which exert anti-tumoral...

    Asghar Zarban, Ehsaneh Azaryan, ... Mohsen Naseri in BMC Complementary Medicine and Therapies
    Article Open access 26 September 2023
  2. Advanced nano-therapeutic delivery of metformin: potential anti-cancer effect against human colon cancer cells through inhibition of GPR75 expression

    The high incidence rate coupled with significant mortality makes colorectal cancer one of the most prevalent and devastating cancers worldwide....

    Fatemeh Ghorbanzadeh, Davoud Jafari-Gharabaghlou, ... Nosratollah Zarghami in Medical Oncology
    Article 29 July 2023
  3. Probucol attenuates high glucose-induced Müller cell damage through enhancing the Nrf2/p62 signaling pathway

    Purpose

    This study investigated the protective effect of probucol on Müller cells exposed to high glucose conditions and examined potential mechanisms...

    Yu-Fan Zhou, Heng-Wei Liu, ... Zhong-** Chen in International Ophthalmology
    Article Open access 09 September 2023
  4. Targeting a mitochondrial E3 ubiquitin ligase complex to overcome AML cell-intrinsic Venetoclax resistance

    To identify molecules/pathways governing Venetoclax (VEN) sensitivity, we performed genome-wide CRISPR/Cas9 screens using a mouse AML line...

    Fumihiko Nakao, Kiyoko Setoguchi, ... Takahiro Maeda in Leukemia
    Article 27 March 2023
  5. Clinicopathologic and mutational profiles of primary breast diffuse large B cell lymphoma in a male patient: case report and literature review

    Introduction

    Primary breast lymphoma (PBL) is rare, and most cases occur in female patients, with few reported cases in male patients. The clinical...

    Fengbo Huang, Yachao Ruan, ... **hua Yang in World Journal of Surgical Oncology
    Article Open access 26 October 2023
  6. Identification of a novel five ferroptosis-related gene signature as a promising prognostic model for breast cancer

    Background

    Breast cancer (BCa) is a major challenge for women’s health worldwide. Ferroptosis is closely related to tumorigenesis and cancer...

    Tian- cheng Cheng, Jia-hao Wu, ... Wei-xian Chen in Journal of Cancer Research and Clinical Oncology
    Article Open access 20 September 2023
  7. Chidamide and orelabrutinib synergistically induce cell cycle arrest and apoptosis in diffuse large B-cell lymphoma by regulating the PI3K/AKT/mTOR pathway

    Objective

    The initial therapeutic approach for diffuse large B-cell lymphoma (DLBCL) entails a rituximab, cyclophosphamide, doxorubicin, vincristine,...

    Chunyan Wu, Shilv Chen, ... Shaoling Wu in Journal of Cancer Research and Clinical Oncology
    Article Open access 21 February 2024
  8. The usefulness of lutein/trypan blue vital dye for the staining of corneal endothelium: a pilot study on DMEK pretreated tissues

    Purpose

    The study aims to evaluate the usefulness of lutein/trypan blue vital dye for the staining of corneal tissues and endothelium–Descemet...

    Rossella Colabelli Gisoldi, Gemma Lodato, ... Augusto Pocobelli in Graefe's Archive for Clinical and Experimental Ophthalmology
    Article 29 November 2022
  9. Altered pathways and targeted therapy in double hit lymphoma

    High-grade B-cell lymphoma with translocations involving MYC and BCL2 or BCL6 , usually referred to as double hit lymphoma (DHL), is an aggressive...

    Yuxin Zhuang, **xin Che, ... Haiyan Yang in Journal of Hematology & Oncology
    Article Open access 18 March 2022
  10. Current Treatment Options in Relapsed and Refractory Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma: a Review

    Treatment of relapsed and refractory (R/R) chronic lymphocytic leukemia/small lymphocytic lymphoma (CLL) has changed dramatically over the past...

    Article 06 July 2023
  11. Next-Generation Sequencing—Optimal Sequencing of Therapies in Relapsed/Refractory Chronic Lymphocytic Leukemia (CLL)

    Purpose of Review

    This research paper aims to provide an overview of evidence-based sequencing of therapies in relapsed/refractory chronic lymphocytic...

    Florian Simon, Jan-Paul Bohn in Current Oncology Reports
    Article Open access 08 September 2023
  12. JAK3 mutations and mitochondrial apoptosis resistance in T-cell acute lymphoblastic leukemia

    Resistance to mitochondrial apoptosis predicts inferior treatment outcomes in patients with diverse tumor types, including T-cell acute lymphoblastic...

    Kimberly Bodaar, Natsuko Yamagata, ... Alejandro Gutierrez in Leukemia
    Article 11 April 2022
  13. EBV-positive follicular lymphoma and concurrent EBV-negative diffuse large B-cell lymphoma illustrating branched evolution model and “Hit and Run” hypothesis

    Epstein-Barr virus (EBV) is one of the most common viruses associated with multiple malignancies including hematopoietic, epithelial, and mesenchymal...

    Yukiko Kitagawa, Jess F. Peterson, ... Magdalena Czader in Journal of Hematopathology
    Article 28 July 2022
  14. Hsa_circ_0003928 regulates the progression of diabetic nephropathy through miR-136-5p/PAQR3 axis

    Background

    Diabetic nephropathy (DN) is one of the complications of diabetes and has a high mortality, but its specific pathogenesis is not clear. In...

    W. Zhang, L. Zhang, ... Q. Wang in Journal of Endocrinological Investigation
    Article 05 April 2023
  15. Histopathologic, immunophenotypic, and mutational landscape of follicular lymphomas with plasmacytic differentiation

    Follicular lymphomas with plasmacytic differentiation (FL-PCD) include two major subtypes: one with predominantly interfollicular PCD that usually...

    Sarah E. Gibson, Yen-Chun Liu, ... Steven H. Swerdlow in Modern Pathology
    Article 02 October 2021
  16. Immunophenotypic analysis of angiomyolipoma with epithelial cysts, comparison to mixed epithelial and stromal tumors and epithelial and stromal elements of normal kidney and ovaries

    Angiomyolipoma with epithelial cysts (AMLEC) is a rare variant of renal angiomyolipoma (AML). It is characterized by a conventional AML component...

    Irem Kilic, Sheila Segura, ... Hector Mesa in Virchows Archiv
    Article 17 May 2024
  17. PU.1 negatively regulates tumorigenesis in non-small-cell lung cancer

    PU.1 is a key transcription factor that modulates hematopoietic cell differentiation and is involved in various physiological and pathological...

    **aoxiao Liu, Muli Xu, ... Wenlin Tai in Medical Oncology
    Article 17 January 2023
  18. Investigation of the Therapeutic Effect of Salbutamol on Endometriosis in a Mouse Model

    Endometriosis is an immune chronic inflammatory disease, and there are currently no more effective drugs for treating endometriosis due to its...

    Qin Yu, Long Chen, ... **nmei Zhang in Reproductive Sciences
    Article 09 October 2023
  19. Chemopreventive effect of Betulinic acid via mTOR -Caspases/Bcl2/Bax apoptotic signaling in pancreatic cancer

    Background

    Pancreatic cancer is aggressive with no symptoms until the advanced stage reached. The increased resistance of pancreatic cancer to...

    Yangyang Guo, Hengyue Zhu, ... Linxiao Sun in BMC Complementary Medicine and Therapies
    Article Open access 08 June 2020
  20. Protein kinase RNA-activated controls mitotic progression and determines paclitaxel chemosensitivity through B-cell lymphoma 2 in ovarian cancer

    Anti-tubulin agents, such as paclitaxel, have been used extensively for treatment of several types of cancer, including ovarian, lung, breast, and...

    Ling Yin, Yongji Zeng, ... Jixin Dong in Oncogene
    Article 19 November 2021
Did you find what you were looking for? Share feedback.